Sai Life Sciences Limited Reveals Key Performance Indicators for Multiple Fiscal Years
Hyderabad, May 14, 2026 — Sai Life Sciences Limited has released verified Key Performance Indicators (KPIs) covering performance metrics from Fiscal 2022 through Fiscal 26, alongside half-yearly data for September 30, 2023, and September 30, 2024. The data, verified by Chartered Accountants, provides insights into the company's financial and operational growth across several key dimensions.The verified metrics include critical figures such as Revenue from Operations, Material Margin, EBITDA, and various efficiency ratios, charting the company's trajectory in the biopharma sector.
Key Financial and Operational Metrics
The performance data presented spans multiple time horizons, allowing stakeholders to track year-over-year trends in revenue, profitability, and operational efficiency. The core KPIs verified are detailed below:| Key Performance Indicator | Units | Fiscal 2022 | Fiscal 2023 | Fiscal 2024 | Six Months ended Sep 30, 2023 | Six Months ended Sep 30, 2024 | Fiscal 2025 | Fiscal 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹ in million | 8,695.93 | 12,171.39 | 14,651.78 | 6,423.41 | 6,752.85 | 16,945.70 | 21,924.92 |
| Revenue Growth - YoY | % | - | 39.97% | 20.38% | - | 5.13% | 15.66% | 29.38% |
| Material Margin | ₹ in million | 6,028.32 | 7,945.52 | 10,194.48 | 4,274.17 | 4,980.74 | 12,288.06 | 16,216.00 |
| Material Margin (%) | % | 69.32% | 65.28% | 69.58% | 66.54% | 73.76% | 72.51% | 73.96% |
| EBITDA | ₹ in million | 1,310.63 | 1,822.33 | 3,001.15 | 718.57 | 1,395.04 | 4,247.37 | 6,529.47 |
| EBITDA - YoY | % | - | 39.04% | 64.69% | - | 94.14% | 41.52% | 53.73% |
| EBITDA Margin | % | 15.07% | 14.97% | 20.48% | 11.19% | 20.66% | 25.06% | 29.78% |
| PBT | ₹ in million | 96.95 | 164.08 | 1,092.34 | -197.59 | 372.58 | 2,277.03 | 4,661.92 |
| PAT | ₹ in million | 62.26 | 99.89 | 828.09 | -129.24 | 280.12 | 1,701.32 | 3,489.10 |
| PAT - YoY | % | 0.00% | 60.43% | 729.00% | NA | NA | 105.45% | 105.08% |
| PAT Margin | % | 0.72% | 0.82% | 5.65% | -2.01% | 4.15% | 10.04% | 15.91% |
| ROCE | % | 3.21% | 5.13% | 10.26% | 1.23% | 3.90% | 12.25% | 18.23% |
| ROE | % | 0.71% | 1.12% | 8.49% | -1.48% | 2.68% | 7.99% | 14.05% |
| Net Debt / Equity | Times | 0.84 | 0.80 | 0.75 | 0.82 | 0.73 | -0.04 | 0.01 |
| Net Debt / EBITDA | Times | 5.61 | 3.90 | 2.43 | 9.94 | 5.49 | -0.18 | 0.04 |
| Gross Fixed Asset Turnover | % | 69.02% | 85.81% | 87.25% | 81.64% | 75.37% | 80.07% | 84.11% |
| Net Working Capital Days | No. of days | 204 | 140 | 122 | 113 | 136 | 117 | 86 |
| Inventory Days | No. of days | 139 | 115 | 93 | 113 | 100 | 81 | 86 |
Employee and Staff Strength
Regarding human capital metrics, the company reported a steady increase in its scientific workforce. The total number of scientific staff grew from 1,779 in Fiscal 2022 to 2,125 in Fiscal 2024, and was projected to reach 2,961 in Fiscal 2026.The verified data provides a comprehensive look at Sai Life Sciences Limited's recent financial performance and operational scale, spanning over four years of historical data.
SAILIFE Stock Price Movement
Sai Life Sciences Limited rallied on Thursday, surging 3.10% to settle at ₹1112.5, marking a significant upward move for the pharmaceutical stock. The shares not only hit their 52-week high but also saw strong conviction underpinning the rally, with trading volume reaching 1.25 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.